Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Net Cash Flow (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Net Cash Flow for 4 consecutive years, with $488.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 180.79% year-over-year to $488.0 million, compared with a TTM value of $1.6 billion through Dec 2025, up 232.69%, and an annual FY2025 reading of $1.6 billion, up 232.69% over the prior year.
  • Net Cash Flow was $488.0 million for Q4 2025 at GE HealthCare Technologies, up from $280.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $1.5 billion in Q3 2024 and bottomed at -$604.0 million in Q4 2024.
  • Average Net Cash Flow over 4 years is $250.2 million, with a median of $70.0 million recorded in 2023.
  • Peak annual rise in Net Cash Flow hit 50700.0% in 2023, while the deepest fall reached 1150.0% in 2023.
  • Year by year, Net Cash Flow stood at $931.0 million in 2022, then crashed by 93.34% to $62.0 million in 2023, then tumbled by 1074.19% to -$604.0 million in 2024, then skyrocketed by 180.79% to $488.0 million in 2025.
  • Business Quant data shows Net Cash Flow for GEHC at $488.0 million in Q4 2025, $280.0 million in Q3 2025, and $1.2 billion in Q2 2025.